| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |